Early studies in humans and mice suggest GLP‑1 medications may modestly reduce biological age, but researchers caution that findings are preliminary.
Posts tagged as “weight loss”
In a phase 3 study of 2,339 adults, weekly retatrutide injections produced up to 25% average weight loss after 80 weeks and improved knee pain and sleep apnea.
Three Japanese women developed ketoacidosis after using tirzepatide without medical supervision, prompting experts to call for safer, nutritionally supported weight‑loss practices.
New research indicates that individuals taking GLP-1 medications for weight loss may decrease their physical activity levels, prompting calls for integrated exercise recommendations.
A new drug, apitegromab, is showing promise in preserving lean muscle mass for individuals undergoing significant weight loss, particularly those using popular 'slimming jabs' like tirzepatide.
Skipping snacks before bed can improve weight loss. According to new research, eating breakfast and avoiding your bedtime snack will help in burning fat and…